Dobutamine/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen (.<noinclude>{{DefMeSH}}</noinclude>) |
imported>Howard C. Berkowitz (See how this works when MeSH is supplemented) |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
A [[Adrenergic beta-agonist|beta-2 agonist]] catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after [[myocardial infarction]] or open heart surgery | A [[Adrenergic beta-agonist|beta-2 agonist]] catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after [[myocardial infarction]] or open heart surgery, <noinclude>{{DefMeSH}}</noinclude> and is used as a pharmacological stressor in [[cardiac stress testing]] | ||
Revision as of 02:26, 15 May 2010
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
Dobutamine [r]:
A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery,
This definition is at least in part based on: Anonymous (2024), Dobutamine (English). Medical Subject Headings. U.S. National Library of Medicine. and is used as a pharmacological stressor in cardiac stress testing